Literature DB >> 16791884

Coy decoy with a new ploy: interceptor controls the levels of homeostatic chemokines.

Guttorm Haraldsen1, Antal Rot.   

Abstract

A new subfamily of chemokine receptors is emerging that do not signal along classical G-protein-mediated pathways. Instead, these "silent" receptors efficiently internalize their cognate chemokine ligands, hence their suggested name, "chemokine interceptors", for internalizing receptors. Two of these interceptors, DARC and D6, possess intriguing patterns of tissue expression and are believed to be involved in controlling the local levels of proinflammatory chemokines. In this issue of the European Journal of Immunology, the biochemical properties of a third silent chemokine receptor, CCX-CKR, have been characterized and it is suggested that it may act as a scavenger for homeostatic chemokines, pointing to a broad and significant role for this group of chemokine binding molecules in chemokine biology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16791884     DOI: 10.1002/eji.200636327

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  13 in total

1.  β-Arrestin recruitment and G protein signaling by the atypical human chemokine decoy receptor CCX-CKR.

Authors:  Anne O Watts; Folkert Verkaar; Miranda M C van der Lee; Claudia A W Timmerman; Martien Kuijer; Jody van Offenbeek; Lambertus H C J van Lith; Martine J Smit; Rob Leurs; Guido J R Zaman; Henry F Vischer
Journal:  J Biol Chem       Date:  2013-01-22       Impact factor: 5.157

2.  Overlapping and distinct role of CXCR7-SDF-1/ITAC and CXCR4-SDF-1 axes in regulating metastatic behavior of human rhabdomyosarcomas.

Authors:  Katarzyna Grymula; Maciej Tarnowski; Marcin Wysoczynski; Justyna Drukala; Frederic G Barr; Janina Ratajczak; Magdalena Kucia; Mariusz Z Ratajczak
Journal:  Int J Cancer       Date:  2010-12-01       Impact factor: 7.396

3.  CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-B.

Authors:  Marion Leick; Julie Catusse; Marie Follo; Robert J Nibbs; Tanja N Hartmann; Hendrik Veelken; Meike Burger
Journal:  Immunology       Date:  2009-12-02       Impact factor: 7.397

Review 4.  The role of stromal-derived factor-1--CXCR7 axis in development and cancer.

Authors:  Radoslaw B Maksym; Maciej Tarnowski; Katarzyna Grymula; Joanna Tarnowska; Marcin Wysoczynski; Riu Liu; Boguslaw Czerny; Janina Ratajczak; Magda Kucia; Mariusz Z Ratajczak
Journal:  Eur J Pharmacol       Date:  2009-10-14       Impact factor: 4.432

5.  Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7.

Authors:  Frederic Sierro; Christine Biben; Laura Martínez-Muñoz; Mario Mellado; Richard M Ransohoff; Meizhang Li; Blanche Woehl; Helen Leung; Joanna Groom; Marcel Batten; Richard P Harvey; Carlos Martínez-A; Charles R Mackay; Fabienne Mackay
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-05       Impact factor: 11.205

6.  Opposing roles of murine duffy antigen receptor for chemokine and murine CXC chemokine receptor-2 receptors in murine melanoma tumor growth.

Authors:  Linda W Horton; Yingchun Yu; Snjezana Zaja-Milatovic; Robert M Strieter; Ann Richmond
Journal:  Cancer Res       Date:  2007-10-15       Impact factor: 12.701

Review 7.  Chemerin regulation and role in host defense.

Authors:  Brian A Zabel; Mateusz Kwitniewski; Magdalena Banas; Katarzyna Zabieglo; Krzysztof Murzyn; Joanna Cichy
Journal:  Am J Clin Exp Immunol       Date:  2014-02-27

8.  Solution Structure of CCL19 and Identification of Overlapping CCR7 and PSGL-1 Binding Sites.

Authors:  Christopher T Veldkamp; Eva Kiermaier; Skylar J Gabel-Eissens; Miranda L Gillitzer; David R Lippner; Frank A DiSilvio; Casey J Mueller; Paeton L Wantuch; Gary R Chaffee; Michael W Famiglietti; Danielle M Zgoba; Asha A Bailey; Yaya Bah; Samantha J Engebretson; David R Graupner; Emily R Lackner; Vincent D LaRosa; Tysha Medeiros; Michael L Olson; Andrew J Phillips; Harley Pyles; Amanda M Richard; Scott J Schoeller; Boris Touzeau; Larry G Williams; Michael Sixt; Francis C Peterson
Journal:  Biochemistry       Date:  2015-07-06       Impact factor: 3.162

Review 9.  Atypical chemokine receptors.

Authors:  Maria Helena Ulvmar; Elin Hub; Antal Rot
Journal:  Exp Cell Res       Date:  2011-01-25       Impact factor: 3.905

10.  Comparative modeling of CCRL1, a key protein in masked immune diseases and virtual screening for finding inhibitor of this protein.

Authors:  Mohaddeseh Behjati; Ibrahim Torktaz; Mehrdad Mohammadpour; Gholamreza Ahmadian; Andrew J Easton
Journal:  Bioinformation       Date:  2012-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.